Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.310.300.450.450.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.31 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.31
Mar20250.30
Mar20240.45
Mar20230.45
Mar20220.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.31
3.33
Mar2025 0.3
-33.33
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,186.4 Cr 0.6% 10.9% 39.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

0.6%

10.9%

39.7%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses